Dr. Orr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
96 Johnathan Lucas Street
Dept. of Gynecologic Oncology
Charleston, SC 29425Phone+1 843-792-9300Fax+1 843-792-7799
Education & Training
- University Of PittsburghMS, Clinical and Translational Science, 2020
- UPMC Medical EducationFellowship, Gynecologic Oncology, 2014 - 2017
- University of South Florida MorsaniResidency, Obstetrics and Gynecology, 2010 - 2014
- University of Tennessee Health Science Center College of MedicineClass of 2010
Certifications & Licensure
- SC State Medical License 2020 - 2025
- PA State Medical License 2014 - 2021
- FL State Medical License Active through 2010
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Kunschner Cup - Gynecologic Oncology Faculty Teaching Award University of Pittsburgh/UPMC, 2020
- CREOG Resident Education National Faculty Award American College of Obstetricians and Gynecologists, 2019
- Fellow Award of Excellence in Resident Gyn Education University of Pittsburgh, 2017
- Join now to see all
Clinical Trials
- Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer Start of enrollment: 2019 Jan 28
Publications & Presentations
PubMed
- Cervical Cancer Mortality Among US Women Younger Than 25 Years, 1992-2021.Poria Dorali, Haluk Damgacioglu, Megan A Clarke, Nicolas Wentzensen, Brian C Orr
JAMA. 2025-01-14 - Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892).Sarah E Taylor, Sarah Behr, Kristine L Cooper, Haider Mahdi, Denise Fabian
Cancer Chemotherapy and Pharmacology. 2024-12-14 - Anticoagulation management in gynecologic brachytherapy patients with perioperative or chronic thromboembolic disease: A retrospective analysis.Osagie Igiebor, Samuel Lewis Cooper, Brian Orr, Harriet Eldredge-Hindy
Brachytherapy. 2024-11-09
Abstracts/Posters
- Small cell neuroendocrine carcinoma of the cervix: does treatment sequence and type of hysterectomy improve outcomes?Orr BC, Lin JF, Beriwal S, Edwards RP, Kelley J L III, Olawaiye AB, Comerci JT, Huang M, Courtney-Brooks M, and Sukumvanich P., 2015 SGO Annual Meeting, Chicago, 2015
Press Mentions
- Dr. Orr on Ongoing Biomarker Research in Ovarian CancerJanuary 27th, 2020
- Recurrent Ovarian Cancer: Combination Therapies and New Clinical TrialsAugust 18th, 2020
Committees
- Committee Member, NRG Ovarian Cancer Subcommittee 2023 - Present
- Committee Member, NRG Developmental Therapeutics Committee 2023 - Present
- Committee Member, NRG Immunotherapy Subcommittee 2023 - Present
- Committee Member, NRG Surgical Oncology 2018 - Present
- Fellow Representative, SGO Educational Committee 2014 - 2017
Professional Memberships
- Member
- Member
- Society of Gynecologic OncologyMember
- Member
- Member
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: